EPISODE · Feb 28, 2024 · 39 MIN
Why Rare Cannabinoids Are In Demand with WTR's Jesse Redmond and BayMedica's Jerry Griffin
from WTR Small-Cap Spotlight · host Water Tower Research
Send us Fan MailBayMedica is the commercial business arm of rare cannabinoids-based drug developer InMed Pharmaceuticals (NASDAQ: INM). BayMedica produces and sells synthesized high purity and consistent rare cannabinoid ingredients to the Health & Wellness sector. BayMedica’s business has quickly grown its annual revenues to more than $5 million over the last 12 months.
What this episode covers
Send us Fan Mail BayMedica is the commercial business arm of rare cannabinoids-based drug developer InMed Pharmaceuticals (NASDAQ: INM). BayMedica produces and sells synthesized high purity and consistent rare cannabinoid ingredients to the Health & Wellness sector. BayMedica’s business has quickly grown its annual revenues to more than $5 million over the last 12 months.
NOW PLAYING
Why Rare Cannabinoids Are In Demand with WTR's Jesse Redmond and BayMedica's Jerry Griffin
No transcript for this episode yet
Similar Episodes
Jun 12, 2025 ·30m
Apr 22, 2025 ·32m
Apr 17, 2025 ·16m
Feb 27, 2025 ·0m
Dec 16, 2024 ·39m